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Summary  
 
The non-structural protein 1 (NS1) of the influenza A virus and the protein NS2, which is 
also known as nuclear export protein, play important roles in the infectious life cycle of the 
virus. The objective of this study was to find the degree of conservation in the NS proteins 
and to identify conserved sites of functional or structural importance, which may be 
utilised as potential drug target sites. The analysis was based on 2620 amino acid 
sequences for the NS1 protein and 1195 sequences for the NS2 protein. The degree of 
conservation and potential binding sites were mapped onto the protein structures 
obtained from a combination of experimentally available structure fragments with 
predicted threading models. In addition to high conservation in protein regions of known 
function, novel highly conserved sites have been identified, namely Glu159, Thr171, 
Val192, Arg200, Glu208 and Gln218 on the NS1 protein and Ser24, Leu28, Arg66, Arg84, 
Ser93, Ile97, and Leu103 on the NS2 protein. Using the Q-SiteFinder binding site prediction 
algorithm, several highly conserved binding sites were found including two spatially close 
sites on the NS1 protein, which could be targeted with a bivalent ligand that would 
interfere with double-stranded RNA binding. Altogether, this work reveals novel 
universally conserved residues that are candidates for protein-protein interactions and 
provide the basis for designing universal anti-influenza drugs. 
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1. Introduction 
The Influenza A virus causes a respiratory disease resulting in an average death toll of 
36000 people each year in the United states alone (Molinari et al., 2007). Apart from 
annually recurring epidemics, Influenza A viruses, which infect avian and mammalian 
species have been responsible for devastating pandemics killing at least 40 million people 
in 1918/1919 (Spanish Flu, H1N1) (Johnson & Mueller, 2002) and less serious pandemics in 
1957 (Asian Influenza, H2N2), 1968 (Hong Kong Influenza, H3N2) and 1977 (Russian 
Influenza, H1N1) (Cox & Subbarao, 2000). Influenza pandemics seem to occur when a 
pathogenic avian type virus acquires the capability of efficient human to human 
transmission (Horimoto & Kawaoka, 2005) which may occur due to mutations or 
reassortment of human and avian  RNA segments (Lin et al, 2000). A current threat is an 
avian H5N1 virus, which emerged in May 1997 (Claas et al., 1998; Subbarao et al., 1998) 
and has caused almost 250 human deaths up to 2009 as reported by the World Health 
Organisation (2004). Due to the high mutation rate and emerging resistance against 
neuraminidase inhibitors (Ferraris & Lina, 2008) and amantadine/rimantadine (Rahman et 
al., 2008) it is of utmost importance to investigate viral proteins as potential drug targets.  
The Influenza A virus belongs to the family Orthomyxoviridae. It is a lipid enveloped virus 
with a negative strand RNA genome organised into eight separate segments, which code 
for eleven proteins (reviewed in Kobasa & Kawaoka, 2005; Obenauer et al, 2006). The 
segment eight encodes the non-structural (NS) proteins, namely NS1 and NS2 (NEP). The 
major role of NS1 is to antagonise the antiviral response of the host by preventing the 
activation of NF-kB and induction of Alpha/Beta interferon (Wang et al., 2000). However, 
NS1 is a multifunctional protein that is additionally involved in (i) inhibiting the pre-mRNA 
3’-end processing (Fortes et al., 1994) by binding to two 3’ end processing factors, namely 
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cleavage and polyadenylation specificity factor and poly (A)-binding protein II (Chen et al., 
1999; Nemeroff et al., 1998); (ii) blocking the post-transcriptional processing and nuclear 
export of cellular mRNA (Fortes et al., 1994); (iii) stimulating the translation of matrix (M1) 
proteins (Enami et al., 1994; Marion et al., 1997); (iv) inhibiting the activation of a protein 
kinase that phosphorylates the elf-2 translation initiation factor by binding to double 
stranded RNA (Lu et al., 1995; Aragón et al., 2000); (v) induction of the 
phosphatidylinositol-3-kinase (PI3K)/Akt signalling pathway in order to support virus 
replication (Ehrhardt et al., 2006; 2007). The NS1 protein is 230-237 amino acid residues 
long dependent on the strain and has a molecular mass of approximately 26 kDa (reviewed 
in Hale et al., 2008b). Residues 1-73 form an N-terminal RNA binding domain (RBD) and 
residues 74-230 form a C-terminal effector domain (ED). The full-length protein exists 
most likely as a homodimer (Nemeroff et al., 1995). Specific regions of functional 
importance that have been identified are (Hale et al., 2008b): RNA binding region (residues 
1-73); cleavage and polyadenylation specificity factor 4 (CPSF4) binding region (residues 
175-210); poly (A)-binding protein (PABPN1) binding region (residues 218-225); nuclear 
localization signal 1 (residues 34-38); nuclear localization signal 2 (residues 211-216); 
nuclear export signal (residues 132-141); regions that interact with the regulatory p58β-
subunit of PI3K (residues 89-93, 137-142, 164-167) (reviewed in Ehrhardt & Ludwig, 2009). 
The non-structural protein 2 (NS2) was previously considered to be present in infected 
cells only until it was shown to exist in the viral particle (Richardson & Akkiina, 1991). 
Therefore NS2 is not strictly a non-structural protein and also referred to as nuclear export 
protein (NEP) according to its role in mediating the export of viral ribonucleoproteins from 
the nucleus to the cytoplasm through nuclear export signals and independent interaction 
with human chromosome region maintenance protein Crm1 ( O'Neill et al., 1998; 
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Neumann et al., 2000). The NS2 protein is potentially involved in viral assembly through its 
interaction with the M1 protein that plays a key role in virus assembly (reviewed in Schmitt 
and Lamb, 2005). It consists of 121 amino acid residues and has a molecular mass of 
approximately 15 kDa (Greenspan et al., 1985). Regions of functional importance in the 
NS2 protein that have been reported (Boutet et al., 2007; O'Neill et al., 1998) are the 
Influenza M1 protein binding region (residues 59-116) (Ward et al., 1995; Akarsu et al., 
2003) and a nuclear export signal (residues 11 to 23). 
There are currently no licensed drugs available targeting the NS proteins of the influenza A 
virus but compounds acting against the NS1 protein were identified using a yeast based 
assay (Basu et al., 2009) and high-throughput screening was used for targeting the 
interaction between the NS1 protein and viral RNA (Maroto et al., 2008). The aims of the 
current study were to identify the degree of conservation among all subtypes of influenza 
A viruses so as to suggest potential drug target sites. Furthermore, models of the full-
length protein structures were obtained and the degree of conservation was mapped onto 
the protein structures. Together with a binding pocket analysis, we suggest potential 
binding sites, which may define in-vivo interaction sites as well as provide starting points 
for the design of novel anti-influenza drugs.  
 
2. Methods   
2.1 Sequence analysis and protein structure prediction 
The protein sequences of NS proteins were obtained from the National Centre for 
Biotechnology Information (NCBI) influenza virus resource (Bao et al., 2008). Full-length 
sequences were chosen from all subtypes, all hosts and all lineages until year 2008 
(inclusive), while identical sequences were removed. Both alleles A and B of the NS1 
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protein (Baez et al., 1981) were analysed together. Multiple sequence alignment was 
carried out with MUSCLE 3.6 (Edgar, 2004) using the default parameters for most accurate 
alignment that involved multiple refinements of the alignment until no further 
improvement was achieved typically resulting in 20-24 iterations. The overview of the 
multiple sequence alignment was made with Jalview (Clamp et al., 2004). Sequence 
conservation plots were made with the plotcon program of the EMBOSS package (Rice et 
al., 2000) using a window size of 10 and the default comparison matrix EBLOSUM62. A full 
length protein structure was predicted for the NS1 sequence of the isolate influenza 
A/Indonesia/CDC1032N/2007(H5N1) with the I-TASSER server 
(http://zhang.bioinformatics.ku.edu/I-TASSER/) (Zhang, 2008). The isolate was selected as 
a recent example of an H5N1 virus that infected a human. I-TASSER uses multiple 
threading alignments and iterative simulations and was the top-ranked prediction method 
in the recent Critical Assessment of Protein Structure Prediction (CASP8) exercise (Zhang, 
2008). The reliability of structure prediction results are reported with the TM-score that is 
a number between [0, 1], with a TM score smaller than 0.17 indicating a random model, 
while a TM-score > 0.5 corresponds to two structures of similar topology (Zhang & Skolnic, 
2004). The final model of the NS1 protein structure was generated by replacing 82% of the 
residues of the predicted structure (residues 5-74 and 80-197) with the experimentally 
determined structure PDB-ID 3F5T  (Bornholdt & Prasad, 2008). A model of the NS2 
protein was obtained from the NS2 sequence of the same isolate with I-TASSER. The final 
model was generated by the replacing 48% of the predicted structure (residues 59-116) 
with the experimental structure PDB-ID 1PD3 (63-116) (Akarsu et al., 2003).  
2.2 Identification of conserved regions 
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Conserved regions were identified and mapped onto the protein structures using the web 
based ConSurf server (http://consurf.tau.ac.il/) (Glaser et al., 2003; Landau et al., 2005) 
providing as input the multiple sequence alignment and the protein structure file. The 
degree of conservation is subdivided into nine grades, with grade 1 being lowest and grade 
9 being highest conserved. Ligand binding sites (LBS) were identified with the Q-SiteFinder 
(Laurie & Jackson, 2005) (http://www.modelling.leeds.ac.uk/qsitefinder/) that evaluates 
the interaction energy between a -CH3 van der Waals probe and the protein (Laurie & 
Jackson, 2005). The resulting binding sites were formed from clusters of probes and 
ranked according to the sum of total binding energies for each cluster The ConSurf and Q-
SiteFinder results were combined so as to show conservation and LBS simultaneously. The 
ConSurf-Q-SiteFinder results were obtained by projecting the ConSurf result on the 
structures containing the LBS obtained from Q-SiteFinder server (referred to as Q-
SiteFinder-ConSurf method). 
Protein atomic structures with conservation scores and predicted ligand binding sites will 
be made available upon request. 
 
3. Results  
3.1 Protein sequence multiple alignment 
For the NS1 protein 2620 sequences were obtained from the NCBI Influenza virus resource 
(Bao et al., 2008), which were mainly from avian (64%) and human (24%) viruses. For the 
NS2 protein 1195 sequences were obtained, which were mainly composed of avian (66%) 
and human (24%) sequences. The overview of the multiple sequence alignment shown in 
figure 1 reveals that sequences had a high degree of similarity despite being from  
different lineages of influenza A virus. Overall, the sequence conservation of both proteins 
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was of the same level, but the NS1 protein showed larger variations of the conservation 
pattern than the NS2 protein. In particular, at residue 79 of the NS1 sequence there was a 
low conservation as indicated by the low similarity value as well as light colours in figure 
1A. This was caused by a deletion of the amino acid sequence [T,A][I,M]ASV at residue 79, 
which is the case in 20% of the analysed sequences including the sequence of the 
experimental NS1 protein structure (PDB-ID 3F5T). When discussing individual residues we 
include the count of the 5-residue deletion according to current conventions, i.e. NS1 
residue 105 in our structure is counted as residue 110. Both proteins showed a low 
conservation at the C-terminus.  
3.2 Protein structures 
The predicted protein structure for the NS1 protein was obtained with a TM-score of 0.57 
± 0.15 from the protein prediction server (Zhang, 2008). In order to improve accuracy of 
the model most parts of the predicted model were replaced with the experimentally 
defined structure (Bornholdt & Prasad, 2008) leaving the N-terminal residues 1-5 and C-
terminal residues 198-225 from the modelled structure. For that reason, the NS1 structure 
was virtually identical with the previous x-ray crystallography structure that is described 
here briefly in order to aid further analysis. The two-domain structure is evident from the 
three-dimensional structure shown in figure 2A. The N-terminal domain RNA-binding 
domain (RBD) shown on the right hand side is composed of two long antiparallel α-helices 
joined by a turn followed by a third shorter helix at an angle of 90° to the first two-helix 
bundle. The domain linker extends from approx. Glu70 to Tyr84. The C-terminal effector 
domain (ED) is formed from a 5-strand antiparallel beta-sheet, while a shorter sixth strand 
is oriented in a parallel fashion.  An α-helix from Thr170 to Asn188 packs against this 
surface formed by the β-sheets. Additionally there are shorter α-helical and β-sheet 
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elements in this structure. The C-terminal part from Trp203 to Val230 that was based on 
prediction forms a short anti-parallel β-sheet followed by an α-helix from Gln218 to 
Glu229. 
The NS2 model was obtained from I-TASSER with a TM-score 0.61 ± 0.14, which indicates a 
reliable model with an estimated root mean square deviation of the atomic coordinates to 
the true structure of 6.1 ± 3.8 Å. The protein structure after replacing residues 63-116 with 
the experimental determined fragment (Akaruso et al., 2003) is shown in figure 2B. The 
main structural feature is a four-helix bundle composed of two pairs of antiparallel α-
helices. The predicted structure of the N-terminal residues 1-62 is composed of two 
antiparallel α-helices (helix one and two) that pack against the other two antiparallel 
helices (three and four). Between helix two and three there is a stretch of residues from 
Glu47 to Gln67 forming a short bend α-helix followed by a loop.  
3.3 Conserved residues  
The conserved residues in the NS1 protein and NS2 protein were identified using ConSurf 
server (Glaser et al., 2003; Landau et al., 2005) and are shown in the table 1. Highly 
conserved residues of the grades 7-9 and variable residues of the grades 1-3 were grouped 
together in table 1. Conservation scores were mapped to the protein backbone in figure 2 
and on a spacefill model in figure 3. In the N-terminal RBD of the NS1 protein highly 
conserved residues (grade 9) are located on the inside part of the two-helix bundle facing 
the C-terminal ED. In particular, helix two from Asp29 to Thr49 shows a helical periodicity 
in the number of highest conserved residues, namely Pro31, Arg35, Asp39, Ser42, Arg46 
and Thr49. A similar but less distinguished pattern of conservation is present on the first N-
terminal helix. The linker region shows a substantially lower degree of conservation with 
only Leu69 and Glu72 in the grade 7 category. The C-terminal ED shows conserved 
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residues and variable residues at various positions. A highly conserved (grade 9) residue is 
Met93, which is with three exceptions present in all sequences analysed. This is followed 
by a short α-helix that contains the conserved Glu97-Arg100 (table 1). After a succession of 
highly conserved (grade 9) residues Trp102, Met104 and Pro107 that are highly surface 
exposed, we found significant conservation throughout the third, fourth and fifth anti-
parallel β-sheets, namely Leu130-Val136, Leu146-Thr151 and Val157-Pro162. An α-helix 
packs against the surface formed by the antiparallel β-sheets. Conserved residues in this 
helix tend to be located at the packing interface between the helix and the surface formed 
by β-sheets, in particular Val174, Ala177, Leu181 and Gly184 . These residues most likely 
stabilise the structure by hydrophobic interactions. At the end of this helix we found a 
conserved feature of Glu186-Asn188 that is not involved in intra-protein interactions with 
Trp187 in the grade 9 category.  Other highly conserved residues are Asn190, Gln199, 
Arg200 and Gln218, which is the only conserved residue at the beginning of the C-terminal 
α-helix. 
In the NS2 protein the highest conserved part is the C-terminal helix from Ser93 to Arg114. 
The other parts of the predicted structure contain highly conserved residues at various 
positions including the turns and loops joining the α-helices, namely Ser24 and Trp65-
Arg66. Some highly conserved residues are accessible from the outside, such as Ser17, 
Leu21, Trp65, Arg66, Glu75, Trp78, while others are buried inside. 
3.4 Predicted ligand binding sites  
Among the ten best ligand binding sites (LBS) reported by Q-SiteFinder (Laurie & Jackson, 
2005), five LBS were chosen on the basis of the number of conserved residues around the 
LBS, which are shown in table 2. Note that the sites are not numbered sequentially, but 
the numbers represent the original ranking reported by Q-SiteFinder, whereby the highest-
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ranking binding site is denoted as site number one. In the NS1 protein, site 1 located on 
the effector domain (ED) contains five highly conserved (grade 9) residues, namely Tpr102, 
Met104, Asp119, Arg148 and Glu159. Site 2 is located in the N-terminal RBD and contains 
eight conserved residues out of which Asp12, Arg19, Pro31, Arg35 and Asp39 are highly 
conserved. They are located on inside of the first two helices of the RBD facing the ED. Site 
5 is located on the ED forming a cleft between two of the anti-parallel β-sheets and the 
long α-helix. Met104 and Asp120 surrounding this site are in the highest conservation 
category, while Gln109, Lys110, Ile117, Gln121 and Gly184 are also conserved. Site 6 is 
another binding site identified on the N-terminal RBD domain that contains ten conserved 
residues out of which Ser8, Arg38, Asp39, Ser42 and Arg46 are the highly conserved. 
Similar to site 2, site 6 is located on the side of the two long N-terminal helices facing the 
ED. Site 9 is formed by residues from the RBD from the long α-helix and short α-helix that 
is oriented towards the domain linker region. It contains six conserved residues out of 
which Leu69 is the highly conserved residue.  
In the NS2 protein, site 1 forms a deep cleft inside the four-helix bundle and is accessible 
from the apex of the bundle. Site 1 is surrounded by nineteen conserved residues out of 
which Met1, Leu38, Tyr41, Glu75, Thr98, Ala102 and Leu103 are highly conserved.  Site 2 is 
buried inside the helix bundle but accessible from the side. It contains nine conserved 
residues out of which Leu38 and Tyr41 are highly conserved residues. Site 7 is located at 
the protein surface in an apical position and contains four conserved residues out of which 
Arg84 is highly conserved. Site 8 is located at the apex opposite to site 7. It contains two 
conserved residues out of which Trp65 and Arg66 are the highly conserved residues. 
Notably, site 7 and site 4 have a substantial positive charge. Site 10 is formed from 
residues of the two N-terminal helices and is open to the outside. It contains five 
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conserved residues out of which Gly61 is the highly conserved residue. The combined 
results of sequence conservation and predicted binding sites, here referred to as the Q-
SiteFinder-ConSurf method, are shown in figure 3.  
 
4. Discussion  
4.1 Protein structures 
The objective of this study was to find the degree of conservation in the non-structural 
proteins among the influenza A viruses and to identify previously unknown sites of 
functional or structural importance, which may also form potential drug target sites.  The 
protein structure of the NS1 protein was based largely on a recently published x-ray 
structure (Bornholdt & Prasad, 2008). For the NS2 protein only the structure of the C-
terminal fragment residues 63-116 forming two antiparallel α-helices was know previously 
(Akarsu et al., 2003), while the N-terminal fragment withstood all crystallisation efforts. In 
the x-ray structure the C-terminal fragment was obtained as a dimer, while the full-length 
NS2 protein is monomeric (Lommer & Luo, 2002).  This was convincingly explained by the 
interaction between clustered hydrophobic residues on one side of the helical hairpin. Our 
predicted full-length model explains the existence of monomers, since the hydrophobic 
surface of the C-terminal helical hairpin is matched by a hydrophobic surface of the N-
terminal hairpin. Our NS2 model of the N-terminal fragment is most likely one of several 
conformations, as it was shown to exist in a very flexible conformation (Lommer & Luo, 
2002). 
4.2 Sequence conservation and binding sites of the NS1 protein 
Both alleles A and B of the NS1 genes of all hosts were analysed together in order to 
identify universally conserved features of potentially pandemic viruses that might arise 
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from re-assortment of human and avian viruses. The conserved residues detected on the 
NS proteins may have a functional significance in interaction with other proteins and RNA, 
may be important in stabilising the protein structure (Schueler-Furman & Baker, 2003) or 
may be conserved on the level of nucleotides as packaging signals (Gog et al., 2007). For 
the NS1 protein RBD residues Arg38 and Lys41 are implicated in dsRNA binding (Wang et 
al., 1999) and together with Arg35 they form a nuclear localisation sequence (Greenspan 
et al., 1988). Arg35 and Arg38 are highly conserved (grade 9), while Lys41 is with grade 5 
not among the highest conserved residues. Arg38 and Lys41 are also implicated in the 
inhibition of β-interferon mRNA production by direct interaction with an RNA helicase, the 
cytoplasmic pathogen sensor RIG-I (Opitz et al., 2007; Pichlmair et al., 2006) . Furthermore 
it has been shown that mutation of the highly conserved Ser42 can reduce virus virulence 
(Donelan et al., 2003) possibly by antagonising the host’s interferon response pathways. 
The clusters of highly conserved basic and hydrophilic residues on the inside of the RBD 
facing the ED, are involved in dsRNA binding (Wang et al., 1999; Yin et al., 2007). The 
effector domain (ED) shows a similar degree of conservation. Some of the highly conserved 
residues of the ED, which are buried inside, most likely fulfil a role in stabilising the protein 
structure such as Ala132, Leu144, Ala149, Ile160, Ala177 and Leu181. Residues 81-113 
were reported to interact with a translation initiation factor eIF4F ( Aragón et al., 2000). 
Based on the present analysis we postulate that the conserved residues Tyr89, Ser99, 
Met104, Leu105, Pro107, Gln109 and Lys110 are involved in interaction with eIF4F, while 
other highly conserved residues in this region such as Met93 and Trp102 are stabilising the 
structure, since they are not as exposed to the surface as the previous residues. Together 
with Tyr89 a Met93 residue has been proposed to bind to the C-terminal SH2-domain 
p85β isoform of the lipid kinase PI3K (Hale et al., 2006). Indeed Tyr89 and Met93 are  
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conserved, while Met93 is partially buried inside the protein but Tyr84 is highly surface 
exposed. Other residues involved in p85β interaction include 159 and 162 (Shin et al., 
2007). Both Pro159 and Pro162 are surface exposed yet not highly conserved, but they are 
surrounding a highly surface exposed and conserved Ser160, which may be the key site 
involved in this interaction. 
Additionally the avian influenza virus was shown to hyperactivate PI3K by binding to the 
signalling proteins Crk and/or CrkL (Heikkinen et al., 2008). This involves residues 207-212, 
which are surface exposed yet highly variable. The high variability of these residues clearly 
demonstrates that this interaction is not universal for all influenza A viruses, but restricted 
to avian influenza viruses as reported previously. The  NS1 protein has been implicated in 
the inhibition of mRNA maturation via interaction with the poly(A)-binding protein II 
(PABPII) (Chen et al., 1999) and the cleavage and polyadenylation specificity factor (CPSF30) 
(Twu et al., 2006). Among the PABPII interacting residues reported (218-232), there is no 
significant conservation.  Some of the residues reported to interact with the CPSF30 
subunit of the polyadenylation complex are highly conserved, namely Leu144, Gly184, 
Glu186, Asn188 and the highly surface exposed Tpr187. Residues 123-127 were shown to 
interact with a dsRNA-dependent serine/threonine protein kinase R (PKR) (Min et al., 
2007). Those residues are surface exposed and Lys126 is conserved (grade 8), while the 
other residues are variable. In the recent crystal structure of the NS2 protein (Bornholdt & 
Prasad, 2008) the formation of long chain oligomers was observed, based on electrostatic 
interactions and hydrogen bonding between residues Lys131/Glu97, Thr91/Arg193, 
Glu196/Arg200, Glu152/Leu95, Glu96/Glu152. Among those residues we found only Glu97 
and Arg200 highly conserved (grade 9), while there was moderate conservation (grade 7) 
of residues Lys131 and Glu196. Residues Glu152 and Leu95 were highly variable.   It is 
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therefore less likely that the formation of oligomers is a common feature of NS1 proteins 
in vivo. 
In addition to identifying residues involved in known interactions significant insight into 
new protein-protein interactions and new potential drug target sites can be gained from 
focussing on highly conserved residues, which are not known from previous studies to be 
involved in any interactions. Examples of those are Glu159 located on the ED domain in a 
β-sheet, Thr191/Val192 located in an exposed loop, Arg200 in a short α-helix, Glu208 
located in an exposed turn and Gln218, the only highly conserved residue in the C-terminal 
α-helix (figure 3A).  
In addition to surface exposed residues on the NS1 protein that may fit into binding sites 
of other proteins, the NS1 protein contains binding pockets surrounded by conserved 
residues (figure 3A). The highest ranking binding site one reported by Q-SiteFinder is 
surrounded by the highly conserved residues Trp102, Met104, Asp120, Arg148, Gly158 and 
Glu159, some of which are in the region that interact with translation initiation factor 
eIF4F (see above). This site could form a potential target for small molecule inhibitors of 
protein-protein interactions (Twu et al., 2006). Binding sites two and six are located in-
between highly conserved residues on the RBD such as Arg19, Arg35, and Arg46. These 
binding sites are spatially close with a distance of about 1 nm. This would make it possible 
to design bifunctional inhibitors that target both sites simultaneously and potentially 
interfere with dsRNA binding. Binding site five close to the conserved residues Gln109, 
Lys110, Gln121 and Gly184, some of which may interact with the translation initiation 
factor eIF4F. Overall, the sequence conservation around binding site five is not that high as 
for the previous binding sites. Binding site nine is located close to the moderately 
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conserved Phe14 but other residues surrounding this site do not show a high degree of 
conservation.  
4.3 Sequence conservation and binding sites of the NS2 protein 
The NS2 protein is known to interact with the cellular nuclear export protein Crm1 through 
the exposed Trp78 residue surrounded by several glutamate residues (Akarsu et al., 2003). 
Indeed, Tpr78 is highly conserved as well as two of the four glutamate residues, namely 
Glu74 and Glu75. A further region of functional importance is a nuclear export signal 
formed by residues 11 to 23 (O'Neill et al., 1998), of which Ile12, Arg15, Met16, Ser17 and 
Leu21 are conserved (grades 7-9). Among those residues Ser17 and Leu21 are highest 
conserved and surface exposed, which we propose to be the key residues of the nuclear 
export signal. Other highly conserved surface exposed residues that have not been 
assigned to any function are found throughout the protein, namely Ser24, Leu28, Arg66, 
Arg84, Ser93, Ile97, and Leu103 (figure 3B). Some other highly conserved residues are 
found in buried positions that may have a role in stabilising the structure or may become 
exposed upon conformational change, since the N-terminal domain has been reported as 
highly flexible. 
A variety of binding sites was predicted between the interface of N-terminal and C-
terminal helix dimer forming the four-helix bundle. Since the N-terminal part of our 
structure was based on a computational prediction and furthermore it was shown 
previously to be very flexible, the predicted binding sites may be an artefact of incomplete 
packing between the two helix hairpins. Further molecular dynamics simulations of the 
predicted structure are required to assess the structural stability of the predicted four-
helix bundle and the significance of the predicted binding sites. We will therefore briefly 
discuss binding sites found on the outside of the structure. Binding site seven is located 
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closely to the conserved residues Arg84, Glu91 and Glu96. This could define a previously 
unknown interaction site, which may be investigated as a potential drug target site. 
Binding site eight is exposed at the apex of the helix bundle and close to the highly 
conserved residues Trp65 and Arg66. Binding site 10 is surrounded by less conserved 
residues and shows a very low site volume (table 2). It would not form an ideal drug target 
site. Contrary to the NS1 protein, the NS2 protein does not reveal binding sites on its 
surface that are close enough in space so they could be targeted with a bivalent compound. 
In conclusion it was found that both non-structural proteins showed a pattern of variable 
and conserved residues among all influenza A virus subtypes and hosts. Binding sites near 
conserved residues revealed in this work are potential targets for developing universal 
anti-influenza drugs, which at the same time are less likely to become ineffective due to a 
mutation of the virus into a drug-resistant form. Further work emerging from this study 
needs to characterise the function of the so-far unknown highly conserved residues as well 
as develop lead compounds that target some of the predicted binding sites in highly 
conserved regions. The significance of some binding sites on the NS2 protein should be 
analysed with molecular dynamics simulations taking into account the high flexibility of the 
full-length structure, which has so far withstood all experimental high-resolution methods. 
 
Acknowledgments 
This work was supported by the School of Life Sciences, University of Hertfordshire, UK.  
 
References 
Akarsu, H., Burmeister, W. P., Petosa, C., Petit, I., Muller, C. W., Ruigrok, R. W. H. & 
Baudin, F. (2003). Crystal structure of the M1 protein-binding domain of the 
influenza A virus nuclear export protein (NEP/NS2). EMBO J 22, 4646-4655. 
18 
 
Aragon, T., de la Luna, S., Novoa, I., Carrasco, L., Ortin, J. & Nieto, A. (2000). Eukaryotic 
translation initiation factor 4GI is a cellular target for NS1 protein, a translational 
activator of influenza virus. Mol Cel Biol 20, 6259-6268. 
Baez, M., Zazra, J.J., Elliott, R.M., Young, J.F. & Palese, P. (1981). Nucleotide sequence of 
the influenza A/duck/Alberta/60/76 virus NS RNA: conservation of the NS1/NS2 
overlapping gene structure in a divergent influenza virus RNA segment. Virology 
113, 397-402. 
Bao, Y. M., Bolotov, P., Dernovoy, D., Kiryutin, B., Zaslavsky, L., Tatusova, T., Ostell, J. & 
Lipman, D. (2008). The influenza virus resource at the national center for 
biotechnology information. J Virol 82, 596-601. 
Basu, D., Walkiewicz, M. P., Frieman, M., Baric, R. S., Auble, D. T. & Engel,  D. A. (2009). 
Novel influenza virus NS1 antagonists block replication and restore innate immune 
function. J Virol 83, 1881-1891.  
Bernstein, H. J. (2000). Recent changes to RasMol, recombining the variants. TTIBS 25, 
453-455. 
Bornholdt, Z. A. & Prasad, B. V. V. (2008). X-ray structure of NS1 from a highly pathogenic 
H5N1 influenza virus. Nature 456, 985-U985. 
Chen, Z. Y., Li, Y. Z. & Krug, R. M. (1999). Influenza A virus NS1 protein targets poly(A)-
binding protein II of the cellular 3 '-end processing machinery. EMBO J 18, 2273-
2283. 
Claas, E. C. J., Osterhaus, A., van Beek, R., De Jong, J. C., Rimmelzwaan, G. F., Senne, D. A., 
Krauss, S., Shortridge, K. F. & Webster, R. G. (1998). Human influenza A H5N1 virus 
related to a highly pathogenic avian influenza virus. Lancet 351, 472-477. 
Clamp, M., Cuff, J., Searle, S. M. & Barton, G. J. (2004). The Jalview Java alignment editor. 
Bioinformatics 20, 426-427. 
Cox, N. J. & Subbarao, K. (2000). Global epidemiology of influenza: Past and present. 
Annual Rev Med 51, 407-421. 
Donelan, N. R., Basler, C. F. & Garcia-Sastre, A. (2003). A recombinant influenza A virus 
expressing an RNA-binding-defective NS1 protein induces high levels of beta 
interferon and is attenuated in mice. J Virol 77, 13257-13266. 
Edgar, R. C. (2004). MUSCLE: multiple sequence alignment with high accuracy and high 
throughput. Nucl Acids Res 32, 1792-1797. 
Ehrhardt, C. & Ludwig, S. (2009). Cell Microbiol, available online, doi: 10.1111/j.1462-
5822.2009.01309.x 
Ehrhardt, C., Marjuki, H., Wolff, T., Nurnberg, B., Planz, O., Pleschka, S. & Ludwig, S. 
(2006). Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza 
virus infection and host cell defence. Cell Microbiol 8, 1336-1348. 
Ehrhardt, C., Wolff, T., Pleschka, S., Planz, O., Beermann, W., Bode, J.G., Schmolke, M., 
Ludwig, S. (2007). Influenza A virus NS1 protein activates the PI3K/Akt pathway to 
mediate antiapoptotic signaling responses.  J Virol 81, 3058-3067.  
Enami, K., Sato, T. A., Nakada, S. & Enami, M. (1994). Influenza-virus NS1 protein 
stimulates translation of the M1 protein. J Virol 68, 1432-1437. 
Ferraris, O. & Lina, B. (2008). Mutations of neuraminidase implicated in neuraminidase 
inhibitors resistance. J Clin Virol 41, 13-19. 
Fortes, P., Beloso, A. & Ortin, J. (1994). Influenza virus NS1 protein inhibits pre-messenger 
RNA splicing and blocks messenger RNA nucleocytoplasmic transport. EMBO J 13, 
704-712. 
19 
 
Glaser, F., Pupko, T., Paz, I., Bell, R. E., Bechor-Shental, D., Martz, E. & Ben-Tal, N. (2003). 
ConSurf: Identification of Functional Regions in Proteins by Surface-Mapping of 
Phylogenetic Information. Bioinformatics 19, 163-164. 
Gog, J.R., Dos Santos Afonso, E., Dalton R.M., Leclercq, I., Tiley, L., Elton, D., von 
Kirchbach, J.C., Naffakh, N., Escriou, N., Digard, P. (2007). Codon conservation in 
the influenza A virus genome defines RNA packaging signals. Nucleic Acids Res 35, 
1897-1907. 
Greenspan, D., Krystal, M., Nakada, S., Arnheiter, H., Lyles, D. S. & Palese, P. (1985). 
Expression of influenz virus NS2 nonstructural proteins in bacterial and localization 
of NS2 in infected eukaryotic cells. J Virol 54, 833-843. 
Greenspan, D., Palese, P. & Krystal, M. (1988). Two nuclear localisation signals in the 
influenza virus NS1 nonstructural protein. J Virol 62, 3020-3026. 
Hale, B.G., Jackson, D., Chen, Y.H., Lamb, R.A. & Randall, R.E. (2006). Influenza A virus 
NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. 
Proc Natl Acad Sci 103, 14194-14199. 
Hale, B. G., Batty, I. H., Downes, C. P. & Randall, R. E. (2008a). Binding of influenza A virus 
NS1 protein to the inter-SH2 domain of p85 beta suggests a novel mechanism for 
phosphoinositide 3-kinase activation. J Biol Chem 283, 1372-1380. 
Hale, B. G., Randall, R. E., Ortin, J. & Jackson, D. (2008b). The multifunctional NS1 protein 
of influenza A viruses. J Gen Virol 89, 2359-2376. 
Heikkinen, L. S., Kazlauskas, A., Melen, K., Wagner, R., Ziegler, T., Julkunen, I. & Saksela, 
K. (2008). Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL 
src homology 3 domains to activate host cell signaling. J Biol Chem 283, 5719-5727. 
Horimoto, T. & Kawaoka, Y. (2005). Influenza: Lessons from past pandemics, warnings 
from current incidents. Nature Rev Microbiol 3, 591-600. 
Johnson, N. & Mueller, J. (2002). Updating the accounts: global mortality of the 1918-
1920 "Spanish" influenza pandemic. Bull Hist Med 76, 105-115. 
Kobasa, D. & Kawaoka, Y. (2005). Emerging influenza viruses: Past and present. Curr Mol 
Med 5, 791-803. 
Landau, M., Mayrose, I., Rosenberg, Y., Glaser, F., Martz, E., Pupko, T. & Ben-Tal, N. 
(2005). ConSurf 2005: the projection of evolutionary conservation scores of 
residues on protein structures. Nucl Acids Res 33, W299-W302. 
Laurie, A. T. R. & Jackson, R. M. (2005). Q-SiteFinder: an energy-based method for the 
prediction of protein-ligand binding sites. Bioinformatics 21, 1908-1916. 
Lin, Y. P., Shaw, M., Gregory, V., Cameron, K., Lim, W., Klimov, A., Subbarao, K., Guan, Y., 
Krauss, S., Shortridge, K., Webster, R., Cox, N., & Hay, A. (2000). Avian-to-human 
transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and 
H5N1 human isolates. Proc Natl Acad Sci 97, 9654–9658. 
Lommer, B. S. & Luo, M. (2002). Structural plasticity in influenza virus protein NS2 (NEP). J 
Biol Chem 277, 7108-7117. 
Lu, Y., Wambach, M., Katze, M. G. & Krug, R. M. (1995). Binding of the influenza-virus NS1 
protein to double-stranded RNA inhibits the activation of the protein kinase that 
phosphorylates the ELF-2 translation initiation factor. Virology 214, 222-228. 
Molinari, N.M., Ortega-Sanchez, I.R., Messonnier, M.L., Thompson, W.W., Wortley, P.M., 
Weintraub, E., et al. (2007). The annual impact of seasonal influenza in the US: 
Measuring disease burden and costs. Vaccine 25, 5086-5096. 
20 
 
Marión, R.M., Aragón, T., Beloso A., Nieto, A., Ortín, J. (1997). The N-terminal half of the 
influenza virus NS1 protein is sufficient for nuclear retention of mRNA and 
enhancement of viral mRNA translation. Nucleic Acids Res 25, 4271-4277. 
Maroto, M., Fernandez, Y., Ortin, J., Pelaez, F. & Cabello, M. A. (2008). Development of 
an HTS assay for the search of anti-influenza agents targeting the interaction of 
viral RNA with the NS1 protein. J Biomol Screen 13, 581–590. 
Min, J. Y., Li, S. D., Sen, G. C. & Krug, R. M. (2007). A site on the influenza A virus NS1 
protein mediates both inhibition of PKR activation and temporal regulation of viral 
RNA synthesis. Virology 363, 236-243. 
Nemeroff, M. E., Barabino, S. M. L., Li, Y. Z., Keller, W. & Krug, R. M. (1998). Influenza 
virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3 ' 
end formation of cellular pre-mRNAs. Molecular Cell 1, 991-1000. 
Nemeroff, M. E., Qian, X. Y. & Krug, R. M. (1995). The influenza virus NS1 protein forms 
multimers in-vitro and in-vivo. Virology 212, 422-428. 
Neumann, G., Hughes, M. T. & Kawaoka, Y. (2000). Influenza A virus NS2 protein mediates 
vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J 19, 
6751-6758. 
Obenauer, J.C., Denson, J., Mehta, P.K., Su, X., Mukatira, S., Finkelstein, D.B., Xu, X., 
Wang, J., Ma, J., Fan, Y., Rakestraw, K.M., Webster, R.G., Hoffmann, E., Krauss, S., 
Zheng, J., Zhang, Z. &  Naeve, C.W. (2006). Large-scale sequence analysis of avian 
influenza isolates, Science 311, 1576–1580. 
O'Neill, R. E., Talon, J. & Palese, P. (1998). The influenza virus NEP (NS2 protein) mediates 
the nuclear export of viral ribonucleoproteins. EMBO J 17, 288-296. 
Opitz, B., Rejaibi, A., Dauber, B., Eckhard, J., Vinzing, M., Schmeck, B., Hippenstiel, S., 
Suttorp, N. & Wolff, T. (2007). IFN beta induction by influenza A virus is mediated 
by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9, 930-938. 
Pichlmair, A., Schulz, O., Tan, C. P., Naslund, T. I., Liljestrom, P., Weber, F. & Sousa, C. R. 
E. (2006). RIG-I-mediated antiviral responses to single-stranded RNA bearing 5 '-
phosphates. Science 314, 997-1001. 
Rahman, M., Bright, R. A., Kieke, B. A., Donahue, J. G., Greenlee, R. T., Vandermause, M., 
Balish, A., Foust, A., Cox, N. J., Klimov, A. I., Shay, D. K. & Belongia, E. A. (2008). 
Adamantane-resistant influenza infection during the 2004-05 season. Emerg Infect 
Dis 14, 173-176. 
Rice, P., Longden, I. & Bleasby, A. (2000). EMBOSS: The European molecular biology open 
software suite. Trends in Genet 16, 276-277. 
Richardson, J.C., Akkina, R.K. (1991). NS2 protein of influenza virus is found in purified 
virus and phosphorylated in infected cells. Arch Virol 116, 69-80. 
Sayle, R. A. & Milnerwhite, E. J. (1995). RASMOL – biomolecular graphics for all. Trends 
Biochem Sci 20, 374-376. 
Schmitt, A.P., Lamb, R.A. (2005). Influenza Virus Assembly and Budding at the Viral 
Budozone. Adv Virus Res 64, 383-416. 
Schueler-Furman, O. & Baker, D. (2003). Conserved residue clustering and protein 
structure prediction. Protein Struct Funct and Genet 52, 225-235. 
Shin, Y.K., Liu, Q., Tikoo, S.K., Babiuk, L.A., & Zhou, Y. (2007). SH3 binding motif 1 in 
influenza A virus NS1 protein is essential for PI3K/Akt signalling pathway activation. 
J Virol 81, 12730-12739. 
21 
 
Subbarao, K., Klimov, A., Katz, J., Regnery, H., Lim, W., Hall, H., Perdue, M., Swayne, D., 
Bender, C., Huang, J., Hemphill, M., Rowe, T., Shaw, M., Xu, X. Y., Fukuda, K. & 
Cox, N. (1998). Characterization of an avian influenza A (H5N1) virus isolated from 
a child with a fatal respiratory illness. Science 279, 393-396. 
Twu, K. Y., Noah, D. L., Rao, P., Kuo, R. L. & Krug, R. M. (2006). The CPSF30 binding site on 
the NS1A protein of influenza A virus is a potential antiviral target. J Virol 80, 3957-
3965. 
Wang, W., Riedel, K., Lynch, P., Chien, C. Y., Montelione, G. T. & Krug, R. M. (1999). RNA 
binding by the novel helical domain of the influenza virus NS1 protein requires its 
dimer structure and a small number of specific basic amino acids. RNA 5, 195-205. 
Wang, X. Y., Li, M., Zheng, H. Y., Muster, T., Palese, P., Beg, A. A. & Garcia-Sastre, A. 
(2000). Influenza A virus NS1 protein prevents activation of NF-kappa B and 
induction of alpha/beta interferon. J Virol 74, 11566-11573. 
Ward, A. C., Castelli, L. A., Lucantoni,  A. C., White, J. F., Azad, A. A. & Macreadie,  I. G. 
(1995). Expression and analysis of the NS2 protein of influenza A virus. Arch Virol 
140, 2067-73. 
World Health Organisation (2004). Avian influenza A(H5N1). Weekly Epidemiol Rec 79, 65-
70. 
Yin, C. F., Khan, J. A., Swapna, G. V. T., Ertekin, A., Krug, R. M., Tong, L. & Montelione, G. 
T. (2007). Conserved surface features form the double-stranded RNA binding siteof 
non-structural protein 1 (NS1) from influenza A and B viruses. J Biol Chem 282, 
20584-20592. 
Zhang, Y. (2008). I-TASSER server for protein 3D structure prediction. BMC Bioinf 9, 40. 
Zhang, Y., Skolnick, J. (2004). Scoring function for automated assessment of protein 
structure template quality. Proteins 57, 702-710. 
 
 
 
22 
 
Table 1:  Conserved residues and variable residues of the NS1 and NS2 proteins identified 
using ConSurf server (Glaser et al., 2003; Landau et al., 2005).  
 
  
Residues NS1 protein NS2 protein 
Conserved* Met1, Asp2, THR5, Ser8-His17, Arg19, Lys20, Ala23, 
Asp24, Gly28-Phe32, Asp34, Arg35, Arg37-Asp39, 
Gln40, Ser42,  Leu43, Gly45, Arg46, Thr49, Leu50, 
Ile54, Ala57, Thr58, Gly61,  Ile64, Leu69, Glu72, 
Tyr89**, Asp92, Met93, Glu97-Arg100, Trp102, 
Met104, Leu105, Pro107, Gln109, Lys110, Leu115, 
Ile117, Asp120-Ala122, Lys126, Ile128, Leu130-
Val136, Leu141, Leu144, Leu146-Thr151, Gly154, 
Val157-Pro162, Ser165, Gly168, His169, Glu172-
Lys175,  Ala177, Ile178, Leu181, Ile182, Gly184, 
Glu186-Asn188, Asn190-Val192, Ser195, Glu196, 
Gln199-Phe201, Trp203, Glu208, Gln218 
Met1, Thr5, Ser8-Gln10, Ile12, Arg15-
Ser17, Lys18, Gln20, Leu21, Ser24, 
Ser25, Leu28, Gly30, Thr33, Ser37, 
Leu38, Tyr41-Asp43, Leu45, Gly46, 
Met50, Arg51, Gly53,  Asp54, Gln59, 
Arg61, Asn62, Trp65 Arg66, Leu69, 
Lys72-Glu75, Arg77-Ile80, Gly82,  
Arg84,  Leu87, Thr90, Glu91, Ser93-
Phe99, Gln101-Leu106, GLu108-
Glu110, Glu112, Arg114, Ser117, 
Gln119, Ile121 
Variable* Ser3, Val6, Phe22, Glu26, Leu27, Lys44, Gly47,  
Asn48, Asp53, Glu55, Arg59, Ala60, Gln63, Arg67,  
Glu70, Glu71, Asp74-Leu77, Lys79-Arg83**, Leu90, 
Leu95, Asp101, Phe103, Val111, Ala112, Cys116, 
Met124, Asp125, Thr127, Ile129, Ile137-Gly139, 
Glu152, Glu153, Ala155, Gly171, Val180, Leu185, 
Thr197, Arg204-Gly206, Asp209-Asn217,  Arg220, 
Lys221, Arg224, Ile226, Glu227, Val230 
Ser3, Val6, Val14, Ala22, Ser23, Glu26, 
Asp27, Met31, Gln34, Gly36, Lys39, 
Leu40, Asp47-Val49, Met52, Phe55, 
Phe58, Ile60, Gly63, Lys64, Glu67, 
Ser70, Val83, His85, Arg86, Lys88, 
Ile89, Leu107, Phe116, Phe118 
 
* Conserved residues, classified by the ConSurf server with grades 7-9 and variable 
residues classified by the grades 1-3 are grouped together. 
** Residue numbers for the effector domain are numbered conventionally, counting the 
five residue deletion.
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Table 2: Predicted ligand binding sites of the NS1 and NS2 proteins. 
 
Si
te
* 
Residues in the ligand binding sites 
of the NS1 protein 
Site 
volume 
(Å3) 
Si
te
* 
Residues in the ligand binding 
sites of the NS2 protein 
Site 
volume 
(Å3) 
1 Trp102- Met104, Lys118-Asp120, 
Ile123, Arg148, Ile156-Glu159**   
165 1 Met1, Ser8, Phe9, Ile12, Leu38, 
Leu40, Tyr41, Ser44, Leu45, Glu47, 
Ala48, Glu75, Ile76, Leu79, Ile80, 
Val83, Arg86, Glu95, Thr98, Phe99, 
Gln101, Ala102, Leu103, Leu105, 
Leu106, Val109 
466 
2 Asp12, Leu15, Trp16, Arg19, Pro31- 
Leu33, Arg35, Leu36, Asp39   
229 2 Ile12, Met16, Thr33, Gln34, Ser37, 
Leu38, Tyr41, Lys72, Ile76,  Val109, 
Glu112, Ile113   
192 
5 Met104, Lys108, Gln109, 
Lys109, Ile117, Lys118,  
Met119, Asp120, Gln121,  
Val180, Gly184** 
188 7 Arg84, Leu87, Lys88, Glu91, Gln96, 
Met100   
 
119 
6 Thr5, Val6, Ser8, Phe9, Trp16, 
Arg38, Asp39, Ser42, Leu43, 
Arg46, Leu50   
198 8 Lys64, Trp65, Arg66, Glu67   
 
108 
9 Phe14, Leu15, His17, Val18, 
Gly61, Lys62, Val65, Glu66, 
Leu69   
146 10 Leu69-Gln71, Phe73, Glu74,  
Glu110, Ile113, Arg114, Ser117   
92 
*The sites are numbered according to the rank obtained from Q-SiteFinder. Only those 
sites are reported here, which are close to conserved residues identified by ConSurf. 
** Residue numbers for the effector domain are numbered conventionally, counting the 
five residue deletion. 
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Figure legends 
 
Figure 1: Overview of the multiple sequence alignment for the NS1 protein (A) and the NS2 
protein (B). Darker shades in the alignment show a higher degree of sequence identity, 
while the line graph shows the degree of conservation within a window of ten residues. 
This figure was made with Jalview (Clamp et al., 2004) and plotcon of the EMBOSS package 
(Rice et al., 2000). 
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Figure 2: Backbone ribbon models of the NS1 protein (A) and NS2 protein (B). The ribbon 
was coloured with conservation scores obtained from ConSurf. The N- and C-termini are 
indicated. The colour codes are explained in figure 3. The inset shows in green the parts of 
the structures that are known from experiments, while the predicted parts are shown in 
grey. This figure was made with RasMol (Sayle & Milnerwhite, 1995; Bernstein, 2000). 
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Figure 3: Conservation score and predicted binding sites shown in a spacefill 
representation of the NS1 protein (A) and NS2 protein (B). Each protein is shown in two 
orientations (180° rotated). The binding sites  are shown in ball-stick format coloured 
green.  This figure was made with RasMol [32, 33] 
 
 
 
